treatment approaches for mutated and unmutated cll
Published 3 years ago • 197 plays • Length 2:20Download video MP4
Download video MP3
Similar videos
-
2:31
treatment considerations for ighv-unmutated and mutated cll
-
3:55
the origins of mutated and unmutated cll
-
2:08
the differences in outcomes and treatment in cll patients with mutated and unmutated ighv
-
2:36
treatment approaches to cll with high-risk molecular features
-
1:18
the use of genomics to help select treatment in cll
-
2:32
ifcg for first-line treatment of ighv-mutated cll
-
1:35
ifcg: a promising new regimen for treating ighv-mutated cll
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
2:59
reducing the risks of chemotherapy in ighv-mutated cll
-
1:29
the importance of treatment sequencing in cll
-
0:56
the current treatment landscape in cll
-
1:43
long-term outcomes of the ifcg regimen for firstline treatment of patients with ighv-mutated cll
-
1:28
the future of cll treatment
-
3:41
personalised medicine in cll: redefining the treatment approach
-
1:59
moving towards a personalized treatment approach in cll
-
1:50
the impact of ighv mutational status in treatment decisions in cll
-
2:19
long-term management of cll for improved outcomes
-
1:44
the impact of acalabrutinib treatment by line of therapy in patients with cll
-
2:14
novel approaches to first line cll treatment